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Background: Trachoma is the leading infectious cause of blindness worldwide and is nearing elimination as a
public health problem in Guinea Bissau. It is imperative that elimination is followed by a successful postvalida-
tion surveillance programme. The aim of this study was to determine the acceptability and perceived utility of
different diagnostic tests and sample types that could be used for postvalidation trachoma surveillance in the
Bijagos Islands, Guinea Bissau.
Methods: Semistructured interviews with community members and stakeholders involved in trachoma elimina-
tion were followed by focus group discussions with community members, covering experiences with trachoma
and views on trachoma diagnostic methods and sample types.
Results: In this setting, all diagnostic tests and sample types used for trachoma surveillance were generally
considered acceptable by communities. A preference for laboratory-based testing andfinger-prick blood samples
was expressed as these results were considered more accurate and applicable to a range of diseases beyond
trachoma.
Conclusions: Appropriate community and stakeholder engagement and communication regarding the purpose
and processes around diagnostic practice prior to trachoma programme implementation are crucial for long-
term successful disease-elimination efforts.
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Introduction
Trachoma, one of 20 neglected tropical diseases (NTDs), is the
leading infectious cause of blindness worldwide.1 It is caused by
recurrent infectionwith ocular strains of the bacterium Chlamydia
trachomatis. Trachoma initially presents as a follicular conjunc-
tivitis, often accompanied by conjunctival inflammation. Over
time, repeat infections can result in fibrosis and scarring of the
conjunctiva, inturned eyelashes that scratch the eyeball (trichi-
asis), corneal opacification and ultimately blindness.2 Trachoma
has been targeted for global elimination as a public health prob-
lem through the WHO-endorsed SAFE strategy (surgery, antibi-
otics, facial cleanliness and environmental improvement).3 For
global elimination of trachoma as a public health problem to be
reached and maintained, full implementation of the SAFE strat-
egy is required.4
WHO recommends clinical examination of the upper tarsal
conjunctiva to diagnose active trachoma, using the WHO-
simplified grading system, which provides an easy and reli-
able method to classify the disease at the community level.5
The prevalence of the clinical signs of trachomatous inflamma-
tion, follicular (TF) and trachomatous trichiasis (TT), determine
whether trachoma is a public health problem, defined as preva-
lences at the evaluation unit level of ≥5% TF in children aged
1–9 y and/or ≥0.2% TT unknown to the health system in adults
aged ≥15 y. The prevalence of TF also determines the number of
rounds of annualmass drug administration (MDA)with antibiotics
that are required before prevalence is re-evaluated.6
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However, there is poor correlation between the clinical signs of
TF and evidence of C. trachomatis infection, with the prevalence
of TF higher than that of infection, especially post-MDA.7 Con-
sequently, alternative markers for ocular C. trachomatis detec-
tion have been developed and evaluated, including laboratory-
based assays and point-of-care tests (POCTs),8–11 as these may
be more appropriate and sustainable indicators for trachoma
surveillance, especially after elimination validation. These meth-
ods require the collection of samples: conjunctival swabs for anti-
gen or nucleic acid-based detection tests, or finger-prick blood
samples for serology.10
The aim of this study was to determine the acceptability and
perceived utility of different diagnostic tests and sample types
that may have future application in trachoma surveillance in the
Bijagos Islands, Guinea Bissau. The Bijagos Islands are a remote
archipelago of islands lying off the coast of Guinea Bissau. Tra-
choma has been shown to be a public health problem on the
archipelago, with the national baseline trachoma survey con-
ducted in 2005 estimating TF prevalence in 1–9 y-olds to be
21.4% and TT prevalence in≥15 y-olds to be 7.7%.12 Subsequent
cross-sectional population-based prevalence surveys found the
prevalence of TF and C. trachomatis in 1–9 y-olds and TT in ≥15
y-olds to be 22.0%, 25.4% and 3.5%, respectively, in 2012,13 and
7.4%, 6.6% and 5.1%, respectively, in 2014 after a single round of
MDA.14 These prevalences exceed WHO thresholds for trachoma
elimination. However, following several years of SAFE implemen-
tation during 2012–2016, including MDA with azithromycin for
active trachoma and ∼800 TT surgeries in total since 2015, the
Bijagos Islands are now nearing the elimination thresholds.15 The
Bijagos Islands have also been the location for research involv-
ing the collection of conjunctival samples in addition to clinical
examination for trachoma diagnosis13,16,17 and blood samples
for the detection of sexually transmitted infections (STIs).18 They
were therefore an ideal setting for this study.
Materials and Methods
Study design
Semi-structured interviews (SSIs) were held with two groups,
community members in Bubaque, the island in the Bijagos
archipelago with the largest population, and key stakeholders
working on the Guinea Bissau trachoma programme. The SSIs
were followed by focus group discussions (FGDs) with commu-
nity members in Bubaque. All data were collected in June and
July 2018.
Recruitment of participants
Community SSI participants were sampled using a purposive
snowball technique, whereby in each community, the commu-
nity leader was identified and invited to participate in the study,
and was then asked to identify others to participate in the
study. Additional community residents were also approached for
interview to assess the diversity of views within the commu-
nity. We aimed to recruit equal numbers of male and female
participants across a wide range of ages, with recruitment end-
ing when theme saturation was reached, suggesting that no new
themes would be identified with the inclusion of additional par-
ticipants.19 For stakeholder SSIs, a stakeholder mapping exercise
was conducted to identify individuals who were involved in the
national and regional trachoma programme.
FGDs took place in the community. FGD participants were rec-
ommended and invited to participate by the community leader
and were stratified by age and gender to avoid any undue influ-
ence to respondents’ participation based on other FGDparticipant
gender and age. Each FGD consisted of three or four people, was
held in the community and lasted for ≤1 h.
Data collection and management
Following written informed consent, SSIs and FGDs were con-
ducted with the support of a predesigned topic guide (Sup-
plementary Information 1 and 2). Different topic guides were
used for each interview group as different information was being
collected. Questions were open-ended, with additional follow-
up questions to further explore interviewees’ reasoning and to
encourage information-rich replies. In SSIs and FGDs, community
members were asked about previous experiences with trachoma,
their relationship with health services and health workers, the
acceptability and perceived utility of eye examinations for clinical
signs, conjunctival sample collection with a cotton bud and blood
sample collection. Stakeholders were additionally asked about
how trachoma is diagnosed in the Bijagos Islands and the plan
for surveillance of trachoma postelimination. All SSIs and FGDs
were recordedwith a dictaphone. Community SSIs and FGDs took
place in Creole and dictaphone recordings were translated and
transcribed verbatim by a local English professor. All transcrip-
tions were checked by a native English speaker to ensure trans-
lations were grammatically correct. Stakeholder SSIs took place
in English. Same-day translation, transcription and analysis took
place to identify constructs of interest and emerging themes, as
well as limitations with the data collection process (e.g. certain
scientific terms that were unfamiliar to participants), which were
evaluated to adapt future SSIs and FGDs as necessary.
Community SSIs and FGDs continued until it was deemed that
theme saturation had been reached. As there was a finite num-
ber of stakeholders involved in the trachoma programme, no fur-
ther stakeholder interviews took place once these individuals had
been interviewed.
Framework analysis
To gain insight into the salient themes emerging from the qual-
itative data, a framework approach was employed.20 Combin-
ing grounded theory with an a priori thematic matrix, framework
analysis allows for the iterative development and elaboration of
themes that correspond to specific questions.21 Firstly, transcrip-
tionswere compared, and common themes and subthemeswere
established by reading and rereading through transcriptions and
highlighting passages of text. Within those frequently occurring,
similarities and differences were identified, with coding schemes
developed to label the themes and allow any other subthemes
or trends in the data to be detected and indexed. The emer-
gent themes were refined through an iterative process of data
familiarisation, coding and indexing into a predefined set of cat-
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Table 1. Summary of community member semistructured inter-
view numbers by community, gender and age range
18–49 y 50–69 y 70–99 y
Community Male Female Male Female Male Female
1 1 - 2 2 - -
2 - - 3 - - -
3 - 1 1 2 - -
4 - - - 3 1 -
5 2 - 2 - - -
6 - - 1 - - -
7 - 3 - 1 - -
8 2 1 - 6 4 1
9 2 1 - - - -
Total 7 6 9 14 5 1
Table 2. Summary of community member focus group discussion
numbers by community, gender and age range
18–29 y 30–39 y 40–45 y
Community Male Female Male Female Male Female
1 - 1 3 - - 2
2 3 3 1 - - -
3 1 3 1 1 1 -
Total 4 7 5 1 1 2
acceptability of different sample types and perceived programme
utility; this allowed for a summary of themes to emerge from the
qualitative data.21,22 Emerging themes identified through anal-
ysis were examination anxiety, diagnostic credibility and hierar-
chies of clinical trust.
Results
Summary of participants
Forty-two community SSIs were conducted across nine commu-
nities with an equal number (n=21) of male and female partici-
pants. The age range of SSI participants was 19–95 y with more
50–69-y-old females and more 70–99-year-old males (Table 1).
Six FGDs were conducted across three communities. In each
community, one FGD was formed entirely of male participants
and the other entirely of female participants. The age range of
participants was 18–45 y (Table 2).
Five stakeholder SSIs were conducted. The breakdown of
interviewees by professional role was one ophthalmic doctor,
one ophthalmic nurse, one public health doctor and two non-
governmental organisation (NGO) representatives.
Eye examination and clinical diagnosis
Twenty-six (62%) community SSI respondents had experienced
an eye examination for trachoma diagnosis. Nine of these (35%)
had negative feedback on the use of a light to check for clinical
signs, specifically its brightness and the pain this caused both dur-
ing and after the examination.
The light they used was strong to my eyes. After that I took
maybe one hour without seeing well (female community
member, 59 y, SSI).
Twelve (29%) community SSI participants doubted the utility
of an eye examination to diagnose trachoma. They were unsure
whether simply looking at someone’s eyes was sufficient, sug-
gesting that theywould feelmore confident about their diagnosis
if more modern methods had been utilised.
Forme it is not good. There is nomachine. I prefer amachine
because it is possible to see which problems somebody has
(female community member, 60 y, SSI).
Stakeholders were supportive of clinical diagnosis as the pri-
mary method of diagnosis, reporting that it was quick, easy and
useful.
It is a test that is in line with WHO guidelines. It is in line
with best practice. It is happening all around the world and
of course in trachoma-endemic countries. It is very feasible,
anyone can be trained to do it, it is not too difficult to do
(NGO representative).
This is the best way that we have to check, especially when
we are doing fieldwork (ophthalmic nurse).
The drawbacks of eye examinations elucidated by stakehold-
ers include their subjectivity, the standardised training needed
before graders can conduct fieldwork and the neglect that is
shown by graders towards personal hygiene.
It can be subjective…If there is poor personal hygiene it can




Most community members were in favour of conjunctival sam-
ples, however, six (14%) community SSI participants expressed
concerns surrounding their safety and the potential pain and
damage that may be caused by a cotton bud’s close proximity
to the surface of the eye.
The way they open the eyesmakes us afraid. If they use that
stick they will damage the eyes (female community mem-
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Stakeholders suggested that conjunctival samples were
feasible to carry out in the field and would be accepted by com-
munities.
I think it is relatively easy once you are trained. The swabs
are available and the patients cooperate. It should be easy
to collect the samples (NGO representative).
Blood sample
Three (7%) community SSI participants considered a blood test
necessary to diagnose trachoma, preferring it to any other
method for trachoma diagnosis. This was supported in FGDs.
If they don’t take out blood, how can they discover what you
have? (female community member, 25 y, FGD).
In community SSIs, there were suggestions that blood sam-
ples were preferable to both eye examinations and conjunctival
samples because they did not involve health professionals being
in close proximity to patients’ eyes.
Eyes are too sensitive and we are afraid to lose them. I pre-
fer to take out blood instead of touching my eyes (female
community member, 43 y, SSI).
Laboratory testing
The benefits of laboratory testing to aid diagnosis were high-
lighted by stakeholders who recognised that the presence of folli-
cles is not always pathognomic for trachoma and that laboratory
tests can improve both diagnostic sensitivity and specificity.
I prefer the lab because if you see somebody’s eyes you can’t
say that it is trachoma, you need to test it in the lab to see if
it is or not. Three or four follicles doesn’t mean that it is not
trachoma. Sometimes there are no symptoms (ophthalmic
doctor).
Community members identified that blood or conjunctival
swab samples allowed the use of the laboratory in trachoma
diagnosis, which was perceived to provide more credible results.
For me the one they will take to the lab is good because it
is impossible to use that light to find any disease. I think the
lab is better because they will use a machine to investigate
the disease (male community member, 19 y, FGD).
Stakeholders also thought that taking samples with a cotton
bud enabled laboratory testing to be conducted andwas a useful,
feasible procedure.
I think it is helpful if you take it to the laboratory. When you
take the sample to the laboratory it confirms the bacteria. All
of these tests are complementing each other (public health
doctor).
Eight (19%) community SSI participants thought that a blood
test would be advantageous because the sample can be used to
detect other diseases in addition to trachoma.
This one is the best one because maybe they can discover
another disease. I think they can discover a lot of diseases
including malaria (male community member, 19 y, SSI).
Most community participants supported the idea of samples
being sent to the laboratory for testing in favour of a same-day
diagnosis. They believed that it was important to give the doctor
time and space tomake a diagnosis, suggesting theywould place
greater faith in the diagnosis if they knew it had taken some time
to come to the result.
You can’t ask someone and he gives you answer in the same
day. He has to sit and think about the answer (male commu-
nity member, 42 y, SSI).
While stakeholders were optimistic about the progress that
could be made with laboratory testing, they were also cautious
about the feasibility of its implementation, particularly from a
resource standpoint.
There may be some health system strengthening
needed…There will be additional resources needed to
provide the equipment, to build capacity, to develop skills of
staff. It is not easy, but is worthwhile. It’s a good investment
if it gives better results. We need to invest in the health
system (NGO representative).
Doctors vs nurses
Twenty-six (62%) community SSI participants indicated a pref-
erence for having a doctor carry out a diagnosis or sample
collection.
I prefer a doctor; it doesn’t mean that the nurses are not
good but the doctors havemore knowledge aboutwhat they
are doing (male community leader, 58 y, SSI).
Local doctors vs foreign doctors
Half of community SSI respondents (n=21) insinuated that com-
munities had a predilection to being seen by a foreign doctor
compared with a local doctor, with foreign doctors being asso-
ciated with greater experience and knowledge.
Local doctors tried to help [but] didn’t succeed, so now I
prefer a foreign doctor to do it (male community member,
29 y).
Some people did not like the idea of being seen by a for-
eign doctor who stays for a short period of time before return-
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emphasis on the continuity of care, which they believed could
only be provided by a local doctor.
We think that the local doctor is better because he will stay
here and take care of us. The foreign doctor will come and
then leave (male community member, 19 y).
Discussion
This study of community and stakeholder opinions of trachoma
diagnosis demonstrated that although clinical eye examination
was acceptable tomost, there was a preference for sample types
that did not involve close proximity with the eye and that enabled
laboratory diagnosis. Furthermore, greater confidence in doctors
vs nurses, and foreign vs local doctors, was expressed, although
appreciation of the continuity of care provided by local doctors
was acknowledged.
There were several limitations to this study. First, community
participantswere recommended by the community leader, which
may have led to biased results if only participants in favour with
the community leader were interviewed. Second, a field transla-
tor was needed for community SSIs and FGDs, and later for tran-
script translation. This likely impacted on the ability to ask appro-
priate follow-up questions during the fieldwork discussions, and
nuances in responses may have been lost in translation. Third,
although all of the stakeholders based in Guinea Bissau were
reachable, international stakeholders were not contactable dur-
ing the data collection period of this study. As such, the results
presented lack a global perspective. Local geographical repre-
sentativeness is also limited, as only community participants
from Bubaquewere recruited; different responsesmay have been
obtained from other Bijagos Islands, particularly from those with
less trachoma research study familiarity. There are limited data
comparing the prevalence of trachoma on Bubaque relative to
the other Bijagos Islands, and of the Bijagos Islands to main-
land Guinea Bissau; although research studies have been based
in up to seven islands, reported prevalence results are aggre-
gated.13,14,16,17 The Bijagos Islands are generally homogeneous
sociodemographically, with>90% belonging to the Bijogo ethnic
group.13 However, there are differences in amenities and access
between Bubaque, which is the main port access between main-
land Guinea Bissau and the Bijagos Islands, and the other islands,
such that it would be valuable to extend this work to other islands
in the archipelago. The rural lifestyle is similar to other coastal
areas in West Africa, but the Bijogo ethnic group is culturally dis-
tinct from others on the mainland, perhaps reducing the gener-
alisability of these results.23 Fourth, only adults were recruited,
whereas diagnosis of active trachoma is targeted towards chil-
dren (specifically 1–9 y-olds, as per WHO recommendations).3
Children’s preferences of clinical examination vs sample collec-
tion for laboratory diagnosis may differ from those of the adult
respondents in this study.
This study also had a number of strengths. The views of
community members as well as key stakeholders involved in
the trachoma elimination programme were explored. Further-
more, community member perspectives were explored via both
SSIs and FGDs, enabling triangulation of results. Saturation was
reached early (FGDs were not warranted in the last six communi-
ties), showing agreement in results, and that results were repre-
sentative of the communities the study sample represents.
In general, clinical examination was acceptable to both com-
munity members and stakeholders. Clinical examination is the
current WHO-recommended diagnostic method, with a rigorous
standardisation process in place to certify grader competence
in population-based prevalence surveys and the development
of new tools to further aid diagnostic accuracy.24,25 However, it
is also well recognised that clinical signs are poorly correlated
with ocular C. trachomatis infection, especially after MDA.7 Fur-
thermore, as countriesmove towards postvalidation surveillance,
more sustainable diagnostic methods that can be integrated
into existing national health systems are needed, especially as
it becomes increasingly difficult to train and certify trachoma
graders as trachoma prevalence decreases.25 Ocular or blood
samples that enable laboratory detection are primary ‘alterna-
tive indicator’ candidates,10 as is the use of photography.26
The fear around eye swabs points to the critical importance
of trusting the practitioner performing the procedure, which
reflects cultural and social norms (e.g. preference for doctors
over nurses). These norms within which interventions are imple-
mented must be understood so that programmes can be opti-
mally successful.27 The individual who is communicating with
the community, and the quality of the information they provide,
are important.28 Our results suggest that in the Bijagos Islands,
individuals higher up in the ‘hierarchy’ (well-respected doctors)
would be best placed to do this. There is evidence from the UK to
suggest that when a patient does not see their preferred health-
care professional, reduced levels of trust, confidence and com-
munication are felt by the patient.29 However, given that there is
only one ophthalmologist responsible for the Bijagos Islands, it
is not feasible for them to always conduct trachoma diagnosis.
Furthermore, preference for foreign over local doctors is not sus-
tainable, nor is it to the healthcare system’s benefit to be reliant
on incoming personnel, rather than investing in strengthening in-
country capacity. Stakeholders and community members should
instead develop a pathway for ongoing feedback, allowing for the
development of a rapport which will aid a relationship of mutual
trust.
The preference for sample collection enabling laboratory diag-
nosis was principally due to greater confidence in the objective
results produced by machines and the ability to test for multi-
ple infections. Finger-prick blood samples were preferred over eye
swabs, possibly due to familiaritywith blood sample collection for
malaria diagnosis, which is highly endemic in Guinea Bissau.30 As
a result, large-scale implementation of blood sample collection
should be acceptable and feasible, as the materials and skilled
staff are already in place.
Along with a preference for modern laboratory-based diag-
nostic techniques, there was the need for time to make an accu-
rate diagnosis. Thus, more emphasis was placed on test accu-
racy than speed of result. This resonateswith research conducted
in the field of STI POCTs, where patients’ willingness to wait for
results depended on their reason for clinic attendance.31 How-
ever, limitations to the routine implementation of these novel
diagnostic methods depends on evidence to support their utility
and the capacity to implement them as routine. The main barri-
ers highlighted to carrying this out at scale are the need for an
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facilities and resources to carry out testing. If these alternative
indicators to clinical diagnosis become the internationally agreed
methods for postvalidation surveillance, mechanisms for imple-
menting them at little or no additional cost to health ministries
will need to be identified.11 This is in linewith the 2021–2030NTDs
roadmap, which seeks to meet the 2030 targets in part through
integration and mainstreaming cross-cutting approaches into
national health systems, increasing cost-effectiveness and pro-
gramme coverage.32
Conclusions
Community members and stakeholders were largely accepting
of all trachoma diagnostic methods. However, community mem-
bers expressed fears relating to practices directly involving the
eye, resulting in a preference for blood sample collection. All
respondents perceived benefits of laboratory testing over clinical
examination. For these alternative indicators for trachoma diag-
nosis to become feasible at scale, integration into national health
systems is needed, alongwith investment in resources, personnel
and infrastructure.
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